Erythrocyte DHA level as a biomarker of DHA status in specific brain regions of n-3 long-chain PUFA-supplemented aged rats

British Journal of Nutrition

Volumn 112, Issue 11, 2014, Pages 1805-1818

  Létondor, Anne ^a,b,c   Buaud, Benjamin ^c   Vaysse, Carole ^c   Fonseca, Laurence ^c   Herrouin, Coralie ^c   Servat, Benjamin ^a,b,c   Layé, Sophie ^a,b   Pallet, Véronique ^a,b   Alfos, Serge ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NutriNeuro Bordeaux University   (France)

^c Institut des Corps Gras   (France)

Author keywords

Ageing; Brain; Erythrocytes; n 3 Long chain PUFA supplementation; n 3 PUFA profile

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; MONOUNSATURATED FATTY ACID; N 3 LONG CHAIN POLYUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; SATURATED FATTY ACID; STEARIC ACID; UNCLASSIFIED DRUG; VACCENIC ACID; BIOLOGICAL MARKER; FATTY ACID;

ADULT; AGE; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BRAIN LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; ERYTHROCYTE LEVEL; ERYTHROCYTE MEMBRANE; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID BIOAVAILABILITY; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; HIPPOCAMPUS; LIPID COMPOSITION; MALE; MEASUREMENT ACCURACY; MOLECULAR DYNAMICS; MOLECULAR STABILITY; NONHUMAN; PREFRONTAL CORTEX; RAT; RELIABILITY; ANIMAL; BLOOD; BRAIN; BRAIN CORTEX; DRUG EFFECTS; MEMORY; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; WISTAR RAT;

RATTUS;

AGING; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; HIPPOCAMPUS; MALE; MEMORY; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; RATS; RATS, WISTAR;

EID: 84925581168     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514002529     Document Type: Article

References (54)

1. Denis I, Potier B, Vancassel S, et al. (2013) Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev 12, 579-594.
2. Su HM (2010) Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 21, 364-373.
3. Cunnane SC, Plourde M, Pifferi F, et al. (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239-256.
4. Guesnet P & Alessandri JM (2011) Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - implications for dietary recommendations. Biochimie 93, 7-12.
5. Horrocks LA & Farooqui AA (2004) Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 70, 361-372.
6. Rapoport SI & Igarashi M (2009) Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot Essent Fatty Acids 81, 119-123.
7. Rapoport SI (2013) Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo. Prostaglandins Leukot Essent Fatty Acids 88, 79-85.
8. Xiao Y, Huang Y & Chen ZY (2005) Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain. Br J Nutr 94, 544-550.
9. Dyall SC, Michael GJ, Whelpton R, et al. (2007) Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging 28, 424-439.
10. Lister JP & Barnes CA (2009) Neurobiological changes in the hippocampus during normative aging. Arch Neurol 66, 829-833.
11. Morrison JH & Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13, 240-250.
12. Mizumori SJ & Jo YS (2013) Homeostatic regulation of memory systems and adaptive decisions. Hippocampus 23, 1103-1124.
13. Sastry PS (1985) Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 24, 69-176.
14. Barcelo-Coblijn G, Hogyes E, Kitajka K, et al. (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100, 11321-11326.
15. Labrousse VF, Nadjar A, Joffre C, et al. (2012) Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLOS ONE 7, e36861.
16. Arranz L, Naudi A, De la Fuente M, et al. (2013) Exceptionally old mice are highly resistant to lipoxidation-derived molecular damage. Age (Dordr) 35, 621-635.
17. Favrelière S, Perault MC, Huguet F, et al. (2003) DHAenriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging 24, 233-243.
18. Little SJ, Lynch MA, Manku M, et al. (2007) Docosahexaenoic acid-induced changes in phospholipids in cortex of young and aged rats: a lipidomic analysis. Prostaglandins Leukot Essent Fatty Acids 77, 155-162.
19. André A, Juanéda P, Sébédio JL, et al. (2005) Effects of aging and dietary n-3 fatty acids on rat brain phospholipids: focus on plasmalogens. Lipids 40, 799-806.
20. Ulmann L, Mimouni V, Roux S, et al. (2001) Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot Essent Fatty Acids 64, 189-195.
21. Favrelière S, Stadelmann-Ingrand S, Huguet F, et al. (2000) Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging 21, 653-660.
22. Latour A, Grintal B, Champeil-Potokar G, et al. (2013) Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1. Aging Cell 12, 76-84.
23. Soderberg M, Edlund C, Kristensson K, et al. (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421-425.
24. Alfos S (2014) Fish oil supplementation prevents age-related memory decline: involvement of nuclear hormone receptors. In Omega 3 Fatty Acids in Brain and Neurologic Health, 1st ed., pp. 147-161 [RR Watson and F De Meester, editors]. San Diego, CA: Elsevier.
25. Ramirez M, Amate L & Gil A (2001) Absorption and distribution of dietary fatty acids from different sources. Early Hum Dev 65, S95-S101.
26. Tu WC, Muhlhausler BS, Yelland LN, et al. (2013) Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins Leukot Essent Fatty Acids 88, 53-60.
27. Stark KD (2008) The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 43, 45-53.
28. Kuratko CN & Salem N Jr (2009) Biomarkers of DHA status. Prostaglandins Leukot Essent Fatty Acids 81, 111-118.
29. Engler MM, Engler MB & Nguyen H (1998) Age-related changes in plasma and tissue fatty acid composition in Fischer 344 rats. Biochem Mol Biol Int 46, 1117-1126.
30. Lepage G & Roy CC (1988) Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J Lipid Res 29, 227-235.
31. Peuchant E, Wolff R, Salles C, et al. (1989) One-step extraction of human erythrocyte lipids allowing rapid determination of fatty acid composition. Anal Biochem 181, 341-344.
32. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
33. Buaud B, Esterle L, Vaysse C, et al. (2010) A high-fat diet induces lower expression of retinoid receptors and their target genes GAP-43/neuromodulin and RC3/neurogranin in the rat brain. Br J Nutr 103, 1720-1729.
34. Morrison WR & Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5, 600-608.
35. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133, Suppl. 3, 925S-932S.
36. Ruggiero FM, Cafagna F, Gadaleta MN, et al. (1990) Effect of aging and acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes. Biochem Biophys Res Commun 170, 621-626.
37. Rapoport SI (2001) In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 16, 243-261.
38. Spector AA (2001) Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci 16, 159-165, discussion 215-221.
39. Christie WW (1985) Rapid separation and quantification of lipid classes by high performance liquid chromatography and mass (light-scattering) detection. J Lipid Res 26, 507-512.
40. Giusto NM, Salvador GA, Castagnet PI, et al. (2002) Ageassociated changes in central nervous system glycerolipid composition and metabolism. Neurochem Res 27, 1513-1523.
41. Kuo YT, So PW, Parkinson JR, et al. (2010) The combined effects on neuronal activation and blood-brain barrier permeability of time and n-3 polyunsaturated fatty acids in mice, as measured in vivo using MEMRI. Neuroimage 50, 1384-1391.
42. 3H-oleic acid tracers. J Mol Neurosci 33, 56-66.
43. Ilincheta de Boschero MG, Roque ME, Salvador GA, et al. (2000) Alternative pathways for phospholipid synthesis in different brain areas during aging. Exp Gerontol 35, 653-668.
44. Lopez GH, Ilincheta de Boschero MG, Castagnet PI, et al. (1995) Age-associated changes in the content and fatty acid composition of brain glycerophospholipids. Comp Biochem Physiol B Biochem Mol Biol 112, 331-343.
45. Guillou H, Zadravec D, Martin PG, et al. (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice. Prog Lipid Res 49, 186-199.
46. Christiansen EN, Lund JS, Rortveit T, et al. (1991) Effect of dietary n-3 and n-6 fatty acids on fatty acid desaturation in rat liver. Biochim Biophys Acta 1082, 57-62.
47. Lim S-Y & Suzuki H (2001) Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J Nutr 131, 319-324.
48. Wainwright PE, Huang YS, Simmons V, et al. (1990) Effects of prenatal ethanol and long-chain n-3 fatty acid supplementation on development in mice. 2. Fatty acid composition of brain membrane phospholipids. Alcohol Clin Exp Res 14, 413-420.
49. Wainwright PE, Xing HC, Mutsaers L, et al. (1997) Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. J Nutr 127, 184-193.
50. Harris WS (2010) The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep 12, 503-508.
51. Pottala JV, Yaffe K, Robinson JG, et al. (2014) Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 82, 435-442.
52. Tan ZS, Harris WS, Beiser AS, et al. (2012) Red blood cell v-3 fatty acid levels and markers of accelerated brain aging. Neurology 78, 658-664.
53. Rapoport SI, Ramadan E & Basselin M (2011) Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat 96, 109-113.
54. Cunnane SC, Schneider JA, Tangney C, et al. (2012) Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 29, 691-697.